Skip to main content

Table 1 Analysis of the demographics and clinical data between late ART initiation and non-late ART initiation groups

From: Trends in baseline CD4 cell counts and risk factors for late antiretroviral therapy initiation among HIV-positive patients in Shanghai, a retrospective cross-sectional study

Characteristics Total Patients (N = 3796) Patients with late ART initiation (N = 2039) Patients without late ART (N = 1757) P-value
Age (Median, IQR) 35(29--48) 38(30--50) 33(27--44) < 0.0001#
Age stratification < 0.0001
  ≤ 30 1273(33.5) 567(28) 706(40.2)  
 31–40 1058(27.9) 546(27) 512(29.1)  
 41–50 704(18.6) 434(21) 270(15.4)  
  ≥ 51 761(20) 492(24) 269(15.3)  
Gender 0.10
 Male 3457(91) 1872(92) 1585(90.2)  
 Female 339(9) 167(8) 172(9.8)  
Marital status < 0.0001
 Married or live together 1583(42) 945(46.3) 638(36)  
 Single 1861(49) 876(43.0) 985(56)  
 Divorced or separated 306(8) 189(9.3) 117(7)  
 Widowed 46(1) 29(1.4) 17(1)  
Infection routes < 0.0001
 PWID 99(2.6) 59(2.9) 40(2.3)  
 Homosexual 2073(54.6) 968(47.5) 1105(62.9)  
 Heterosexual 950(25) 557(27.3) 393(22.4)  
 Othersa 674(17.8) 455(22.3) 219(12.4)  
CD4 cell counts 205(75--287) 88(25--162) 287(245.5--330.5) < 0.0001#
WHO stage 0.24δ
 Stage I 15(0.4) 8(0.4) 7(0.4)  
 Stage II 46(1.2) 14(0.7) 32(1.8)  
 Stage III 2860(75.3) 1142(56) 1718(97.8)  
 Stage IV 875(23.1) 875(42.9) 0(0)  
Time to initiationb (months) 2(1--10) 1.5(1--6) 3(1.5--13) < 0.0001#
Stratification of interval time < 0.0001
  ≤ 3 months 2314(61) 1414(69) 900(51)
 3–12 months 674(18) 266(13) 408(23)  
  > 12 months 808(21) 359(18) 449(28)  
Year of ART initiation < 0.0001
 2008 152(4) 121(5.9) 31(2)  
 2009 254(6.7) 189(9.3) 65(4)  
 2010 420(11.1) 257(12.6) 163(9)  
 2011 601(15.8) 318(15.6) 283(16)  
 2012 703(18.5) 375(18.4) 328(19)  
 2013 1181(31.1) 561(27.5) 620(35)  
 2014c 485(12.8) 218(10.7) 267(15)  
  1. Results are shown as N (%) or the median (Q1--Q3)
  2. ART combined antiretroviral therapy, PWID people who inject drugs
  3. #By Mann-Whitney test
  4. aIncluding transmission via plasma donation (n = 2), mother-to-child transmission (n = 3), blood transmission (n = 55) and undetermined transmission (n = 614)
  5. δThis P value was detected by Chi-square analysis of the WHO stages I, II and stage III groups. The stage IV patients were not included
  6. bTime from the diagnosis of HIV to ART initiation
  7. cComprising data only from January 2014 to June 2014